Oppenheimer initiated coverage of Spruce Biosciences (SPRB) with an Outperform rating and $283 price target. Further to FDA’s confirmation that existing and what the firm views as “compelling” ...
One of the small satellites of the CC [i.e. the ruling Civil Contract Party and its parliamentary faction] "house" declares that the Armenian Apostolic Church must be destroyed. Here, in an interview ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback